BEAM
Price
$29.76
Change
+$1.37 (+4.83%)
Updated
Aug 21 closing price
Capitalization
3.07B
78 days until earnings call
Intraday BUY SELL Signals
PROK
Price
$1.61
Change
+$0.19 (+13.38%)
Updated
Aug 21 closing price
Capitalization
336.37M
85 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs PROK

BEAM vs PROK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BEAM vs. PROK commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (BEAM: $29.76 vs. PROK: $1.61)
Brand notoriety: BEAM and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 96% vs. PROK: 122%
Market capitalization -- BEAM: $3.07B vs. PROK: $336.37M
BEAM [@Biotechnology] is valued at $3.07B. PROK’s [@Biotechnology] market capitalization is $336.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while PROK’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • PROK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PROK is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +11.25% price change this week, while PROK (@Biotechnology) price change was +21.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 09, 2026.

PROK is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($3.07B) has a higher market cap than PROK($336M). BEAM YTD gains are higher at: 7.359 vs. PROK (-28.125). PROK has higher annual earnings (EBITDA): -149.81M vs. BEAM (-349.25M). BEAM has more cash in the bank: 1.21B vs. PROK (225M). PROK has less debt than BEAM: PROK (3.78M) vs BEAM (251M). BEAM has higher revenues than PROK: BEAM (164M) vs PROK (889K).
BEAMPROKBEAM / PROK
Capitalization3.07B336M915%
EBITDA-349.25M-149.81M233%
Gain YTD7.359-28.125-26%
P/E RatioN/AN/A-
Revenue164M889K18,448%
Total Cash1.21B225M539%
Total Debt251M3.78M6,635%
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMPROK
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
70%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 17 days ago
76%
Bullish Trend 19 days ago
75%
Declines
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
71%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
PROK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HILIX28.660.30
+1.06%
Hartford International Value I
LOIEX26.050.25
+0.97%
Lord Abbett International Opps F3
RMDKX12.870.09
+0.70%
American Funds U.S. Sm & Md Cp Eq R-5E
STFBX104.510.34
+0.33%
State Farm Balanced
FHLSX11.77N/A
N/A
Fidelity Health Savings

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RXRX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+13.38%
RXRX - PROK
55%
Loosely correlated
+4.79%
SANA - PROK
50%
Loosely correlated
+4.55%
BEAM - PROK
44%
Loosely correlated
+4.83%
TNXP - PROK
44%
Loosely correlated
+1.29%
NKTX - PROK
44%
Loosely correlated
+7.69%
More